We have decided to establish a joint venture with Beijing 国医汇 (Kokuikai) Medical Inc. which is part of the China-Commercial Alliance Construction and Development Group, which has a total assets of 20 billion USD. In this regard, a contract was signed on December 11, 2019, at the head office of the China-Commercial Alliance Construction and Development Group.
The most prestigious Chinese medicine in Beijing is “北京界同中医研究院” (Beijing Institute of Chinese Medicine). It is located in a temple, and the heads of the world come and visit to find Chinese medicines.
They are all handmade and cannot be mass-produced, resulting in prices to be too high for ordinary people to purchase.
In our business trip, a government official asked us whether this Chinese medicine could be mass-produced using Western medicine pharmaceutical technology.
Western medicine pharmaceutical technology is not only researching ingredients but also researching how to maximize the efficacy in the body.
Therefore, we decided to promote the business of supplementing the Chinese herbal medicine recipe with Western pharmaceutical technology, using the brand of “北京界同中医研究院” (Beijing Institute of Chinese Medicine) in Beijing.
Medical progress is remarkable, and it is always happening that common sense up to yesterday is insane today. For example, with regard to infectious diseases, it is always necessary to keep an eye on the emergence of resistant bacterias, and the phenomenon that antibacterial drugs that had previously been effective are no longer effective nowadays. Also, state-of-the-art medical treatment is becoming more specialized, and even doctors in the same department have surprisingly no knowledge of diseases other than organs they specialize in.
Under the current medical conditions, it is virtually impossible for doctors who deal with patients every day to have the latest medical knowledge in all fields. …
Use cases of ASCA token by Asclepius Network are as follows.
A. Accumulation of Knowledge and its Use
1. Medical researchers around the world participating in the Asclepius Network can mine ASCA tokens by posting their state-of-the-art medical knowledge to the Asclepius Network.
2. The user needs to deposit ASCA tokens to use the knowledge. Basic functions are provided free of charge, but subject to deposit ASCA tokens.
3. Each time a user uses medical knowledge accumulated by the contributor, ASCA tokens are mined to the contributor.
B. Use of Asclepius Network
1. When using Asclepius Network, you can pay with a discounted price with ASCA token. The services users can pay in ASCA token are as follows.
・ Payment for the use of the state-of-the-art electronic medical record system provided by Asclepius Network.
・ Online shopping for supplements, energy drinks, mineral water, etc., certified by Asclepius Network as safe and effective.
・ Payment for postage medical checkups and cancer testing by micro blood collection provided by Asclepius Network.
・ Mining ASCA tokens by downloading health apps provided by the Asclepius Network and performing health checks such as screening, walking more than 8000 steps a day, etc. …
The joint venture company with our Chinese partner “同済堂” will accumulate the following data in blockchain; the purchase history of supplement sales, nutrition drink sales and bio-water sales, as well as data on health examinations and cancer tests using micro blood sampling tests. The company will use them as big data.
The result of the health checkup and the cancer test by using the micro blood sampling test developed by the joint venture company will be notified to the users via the smartphone app. These medical records are stored semi-permanently until the user deletes them arbitrarily, and they can be used at anytime and anywhere as long as the user has an internet connection even outside of China. …
Our joint venture company with Chinese partner “同済堂”, will provide support for agriculture, animal husbandry and aquaculture in China.
In China, environmental pollution including soil pollution is a serious problem. The basics of health lie in food, but if the environment, such as the soil or water source that nurtures the food, is contaminated with harmful substances, the harvests obtained from them will also contain harmful substances. In particular, cadmium, hexavalent chromium, trichloroethylene, etc. are thought to have serious adverse effects on the human body.
A technology to detoxify this harmful substance with biotechnology has been put into practical use in Japan, and it has made remarkable achievements in dioxin purification in Vietnam and soil and water purification in other countries. …
Our joint venture with Chinese partner “同済堂”, will conduct health checkups and cancer tests using micro blood sampling in China.
The population of China is about 1.4 billion people, but it is said that there are 400 million or 600 million more people who are not registered to the government. However, there are very few health examination facilities in the population ratio, and it is said that only about 30% of people have regular health examinations.
We will offer Japanese medical examination technology using micro blood sampling in China through our joint venture company. 13 items can be tested with one drop of blood. …
Our joint venture with Chinese partner “同済堂”, will manufacture and sell mineral water in China.
Currently, in China, the demand for safe drinking water is extremely high due to pollution problems caused by toxic substances such as cadmium, hexavalent chromium, and trichloroethylene in rivers, and the mineral water market exceeds 40 billion dollars.
However, mineral water produced in China has many poor products such as just obtained by filtering normal tap water. Also, safe imports are more than quadruple in price and are too expensive for ordinary people to buy on a daily basis.
We apply biotechnology developed in Japan to produce mineral water in China. This biotechnology is currently producing remarkable effects mainly in soil remediation and improvement in countries in Asia. In Vietnam, dioxin contamination is almost fully removed in the target area. …
The joint venture which we establish with Chinese public company “同済堂” will import, manufacture and sell raw materials for supplements and energy drinks in China. We import, manufacture and sell supplements and energy drinks that have been confirmed to be safe and effective in the state-of-the-art medical and health network which Asclepius Network provides.
In China, health awareness is rapidly increasing with the economic growth.
The government also states health as one of the important themes of the basic policy, and has expressed a strong back-up regarding disease prevention and supplements related to the non-illness stage before getting sick. As a result, the market is expanding rapidly. …